Harold Bernstein, President, R&D & CMO at Maze Therapeutics, Inc. (MAZE), sold 60,000 shares at $50.45 ($3.0M) on 2026-03-10, disclosed to the SEC on 2026-03-12.
Open-market sale of $3.0M MAZE by President, R&D & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.45 | 29,652 | $1.5M | 49.4% |
| 2 | $50.45 | 29,652 | $1.5M | 49.4% |
| 3 | $51.02 | 348 | $18K | 0.6% |
| 4 | $51.02 | 348 | $18K | 0.6% |
| Total | $50.45 avg | 60,000 | $3.0M | 100% |
| Filing → |
| MAZE | SELL | 2026-09-04 | $270K | — | Filing → |
| MAZE | SELL | 2026-09-03 | $426K | — | Filing → |
| MAZE | SELL | 2026-08-14 | $446K | — | Filing → |